Evidence map›Paper›PMID 32349350›Full record

ArticleGenes2020

Telomere and Centromere Staining Followed by M-FISH Improves Diagnosis of Chromosomal Instability and Its Clinical Utility.

Radhia M'kacher, Bruno Colicchio, Claire Borie, Steffen Junker, Valentine Marquet, Leonhard Heidingsfelder, Kevin Soehnlen, Wala Najar, William M Hempel, Noufissa Oudrhiri and 16 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset.Current issues in molecular biology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Telomerase (Genes · 2021
    Article
  13. Article
  14. Using telomeric chromosomal aberrations to evaluate clastogen-induced genomic instability in mammalian cells.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2020
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 4 countries.

Radhia M'kacherCell Environment, DNA Damage R&D, 75020 Paris, France.
Bruno ColicchioIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, 68093 Mulhouse, France.
Claire BorieAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Steffen JunkerInstitute of Biomedicine, University of Aarhus, DK-8000 Aarhus, Denmark.
Valentine MarquetService de Cytogénétique, Génétique Médicale, et Biologie de la Reproduction Hôpital de la Mère et de l'Enfant, CHU Dupuytren, 87042 Limoges, France.
Leonhard HeidingsfelderMetaSystems GmbH, Robert-Bosch-Str., 6 D-68804 Altlussheim, Germany.
Kevin SoehnlenCell Environment, DNA Damage R&D, 75020 Paris, France.
Wala NajarCell Environment, DNA Damage R&D, 75020 Paris, France.
William M HempelCell Environment, DNA Damage R&D, 75020 Paris, France.
Noufissa OudrhiriAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Nadège Wilhelm-MurerService de Génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace Mulhouse, 68070 Mulhouse, France.
Marguerite MiguetService de Génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace Mulhouse, 68070 Mulhouse, France.
Micheline ArnouxAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Catherine FerrapieAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Wendy KerbratAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Andreas PleschMetaSystems GmbH, Robert-Bosch-Str., 6 D-68804 Altlussheim, Germany.
Alain DieterlenIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, 68093 Mulhouse, France.
Theodore GirinskyDepartment of Radiation Oncology, Gustave Roussy Cancer Campus, 94 800 Villejuif, France.
Philippe VoisinCell Environment, DNA Damage R&D, 75020 Paris, France.
Georges DeschenesNephrology Department, APHP-Hopital Robert Debré, 75019 Paris, France.
Anne-Claude TabetCytogenetic Laboratory, APHP-Hopital Robert Debré, 75019 Paris, France.
Catherine YardinService de Cytogénétique, Génétique Médicale, et Biologie de la Reproduction Hôpital de la Mère et de l'Enfant, CHU Dupuytren, 87042 Limoges, France.ORCID 0000-0002-0049-3058
Annelise Bennaceur-GriscelliAPHP-Service d'hématologie Oncohématologie moléculaire et Cytogénétique Hôpital Paul Brousse Université Paris Saclay/ Inserm UMR 935, 94800 Villejuif, France.
Michael FenechSchool of Pharmacy and Medical Sciences, University of South Australia, SA 5000 Adelaide, Australia.
Patrice CardeDepartment of Hematology, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
Eric JeandidierService de Génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace Mulhouse, 68070 Mulhouse, France.ORCID 0000-0002-2757-0770
Inserm · FRGroupe Hospitalier de la Région de Mulhouse et Sud Alsace · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Mère-Enfant · FRInstitut Gustave Roussy · FRRobert Bosch (Germany) · DEUniversité de Haute-Alsace · FRAarhus University · DKDélégation Paris 5 · FRUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dicentric chromosomes are a relevant marker of chromosomal instability. Their appearance is associated with telomere dysfunction, leading to cancer progression and a poor clinical outcome. Here, we present Telomere and Centromere staining followed by M-FISH (TC+M-FISH) for improved detection of telomere dysfunction and the identification of dicentric chromosomes in cancer patients and various genetic syndromes. Significant telomere length shortening and significantly higher frequencies of telomere loss and deletion were found in the peripheral lymphocytes of patients with cancer and genetic syndromes relative to similar age-matched healthy donors. We assessed our technique against conventional cytogenetics for the detection of dicentric chromosomes by subjecting metaphase preparations to both approaches. We identified dicentric chromosomes in 28/50 cancer patients and 21/44 genetic syndrome patients using our approach, but only 7/50 and 12/44, respectively, using standard cytogenetics. We ascribe this discrepancy to the identification of the unique configuration of dicentric chromosomes. We observed significantly higher frequencies of telomere loss and deletion in patients with dicentric chromosomes (

Indexed as

CentromereChromosomal InstabilityChromosome AberrationsCytogenetic AnalysisFemaleHumansIn Situ Hybridization, FluorescenceLymphocytesMaleMetaphaseMiddle AgedNeoplasmsTelomerecancercentromerechromosomal instabilitydicentric chromosomegenetic syndrometelomere

Identifiers

PMID32349350
PMCPMC7291161
OpenAlexW3020022632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.